Clinical Trials Browser

Phase 1/2 × etoposide phosphate × 30 days × Clear all

NCT04663347 2026-03-03

EPCORE™ NHL-2

Phase 1/2 Active not recruiting

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse